Metabolic-Fit / 100
NavioMD review
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
NavioMD at a glance
- Semaglutide
- Ozempic® from $345/mo
- Tirzepatide
- Compounded from $189/mo
- Coverage
- 48 states (not AL or MS)
- Brand-name
- Yes
How we scored NavioMD
Each factor is scored from NavioMD's real pricing, disclosures and oversight, then combined into the 50/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- naviomd.com
Sourced from WLR's provider directory, independently re-verified live on naviomd.com (2026-08-03). All four tiered starting prices (compounded tirzepatide, Ozempic, Zepbound, Mounjaro) confirmed directly on the homepage pricing grid, matching WLR's recorded figures. The 48-state coverage (excluding AL, MS) confirmed via the site's own FAQ. Named pharmacy partner (The Pharmacy Hub) also confirmed via FAQ.
What to expect when you sign up
We walked NavioMD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage leads with 'Meet with a provider instantly' and a tiered pricing grid for both compounded tirzepatide and brand-name Ozempic/Zepbound/Mounjaro
- 2Also offers a women's-hormone menu (progesterone capsules, Biest) alongside weight loss, on the same site
- 3FAQ names its exclusive pharmacy partner directly — The Pharmacy Hub — for both compounded and branded medication fulfillment
- 4States operation in 48 states, explicitly excluding Alabama and Mississippi, with automatic eligibility verification during intake
What we noticed
- No compounded semaglutide option was found on this site — readers wanting semaglutide specifically would need to go the brand-name Ozempic route at a meaningfully higher price ($345/mo vs $189/mo for compounded tirzepatide)
- Same-day provider access is a genuine claim — 'available instantly from the hours of 9am-10pm EST'
- Names its pharmacy partner directly (The Pharmacy Hub), a real transparency plus
- Offers a parallel women's-hormone menu (progesterone, Biest), though nothing pregnancy- or breastfeeding-specific was found
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded tirzepatide | $189 | As low as, tiered by doseListed as 'as low as $189/month'; no compounded semaglutide option was found — semaglutide is only offered as brand-name Ozempic on this site. |
| Brand semaglutide | $345 | Ozempic®, as low as, tiered by doseListed as 'as low as $345/month.' |
| Brand tirzepatide | $445 | Zepbound®, as low as, tiered by doseListed as 'as low as $445/month.' |
| Brand tirzepatide | $1249 | Mounjaro®, as low as, tiered by doseListed as 'as low as $1,249/month' — Mounjaro is tirzepatide's diabetes-indication brand name, listed separately from Zepbound (the weight-loss-indication brand of the same molecule) at a much higher price point. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect NavioMD's public disclosures at last review and change often; confirm the current number on NavioMD's own site.
What we like
- Same-day, instant provider access, per the site — one of the faster claimed timelines in this round
- Names its exclusive pharmacy partner (The Pharmacy Hub) directly
- Offers brand-name Ozempic®, Zepbound®, and Mounjaro® alongside compounded tirzepatide
- Parallel women's-hormone menu (progesterone, Biest) on the same platform
The caveats
- No compounded semaglutide option — semaglutide is only available as brand-name Ozempic at a much higher price
- Not available in Alabama or Mississippi
- No mention anywhere of pregnancy or breastfeeding-specific guidance, despite the parallel women's-hormone menu
- No published statement on whether a video visit is required
NavioMD for mothers: our verdict
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo. It runs about $189/month — a premium to the category, so the extras have to earn it.
We weigh NavioMD the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What NavioMD actually costs
- Compounded tirzepatide — As low as, tiered by dose: $189/mo
- Brand-name semaglutide — Ozempic®, as low as, tiered by dose: $345/mo
- Brand-name tirzepatide — Zepbound®, as low as, tiered by dose: $445/mo
- Brand-name tirzepatide — Mounjaro®, as low as, tiered by dose: $1249/mo
For context, the typical ongoing price across our roster is around $150/month, so NavioMD sits at the premium end.
The medications NavioMD prescribes
NavioMD prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where NavioMD fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
NavioMD is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers open to tirzepatide specifically, or comfortable paying brand-name pricing for semaglutide, who want to talk to a provider the same day rather than wait for async review.
Alternatives to NavioMD
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing NavioMD
Head-to-head & alternatives
NavioMD, answered
- How much does NavioMD cost?
- As last verified, NavioMD's compounded pricing starts around $189/month (Ozempic® from $345/mo semaglutide, Compounded from $189/mo tirzepatide). Confirm the current, all-in price on NavioMD's own site before you commit.
- Is NavioMD safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; NavioMD is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does NavioMD offer both semaglutide and tirzepatide?
- Yes — NavioMD offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does NavioMD rank for mothers?
- NavioMD scores 50/100 on our Metabolic-Fit Score (rank #38), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect NavioMD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.